Medical Director Early Clinical Development

  • Medical Doctor and PhD at University of Copenhagen
  • License to practice independent medicine
  • Specialist in medical oncology and radiotherapy

16 years of Clinical experience, 6 years of basic research and 14 years of drug development.

Key areas of interest include

  • Early clinical development phase I trials
  • Proof of concept trials - randomized phase II trial
  • Development of strategic plans, target product profile, interactions with health authorities

Experience and publications

Nordic medical advisor, Novartis A/S

Duration: 20 months

Medical & Scientific advisor and Medical director oncology, Genmab A/S

Duration: 28 months

Medical Director Oncology, Topotarget A/S (now Onxeo)

Duration: 21 months

Medical Director Oncology, Merck KGaA, Darmstadt

Duration: 74 months

Medical Director Oncology, Symphogen A/S

Duration: 5 months

Medical Director Oncology, Debiopharm International, Lausanne, Switzerland

Duration: 40 months